MiR-96 promotes proliferation and chemo- or radioresistance by down-regulating RECK in esophageal cancer

Biomedicine and Pharmacotherapy

Volumn 68, Issue 8, 2014, Pages 951-958

  Xia, Haifeng ^a   Chen, Shaomu ^a   Chen, Ke ^a   Huang, Haitao ^a   Ma, Haitao ^a  

^a THE FIRST AFFILIATED HOSPITAL OF SOOCHOW UNIVERSITY   (China)

Author keywords

Chemotherapy; EC; MiR 96; Radiotherapy; RECK; Tumor growth

Indexed keywords

ANTINEOPLASTIC AGENT; GLYCOSYLPHOSPHATIDYLINOSITOL ANCHORED PROTEIN; MICRORNA; MIRN96 MICRORNA, HUMAN; RECK PROTEIN, HUMAN;

AGED; ANIMAL; BAGG ALBINO MOUSE; BIOSYNTHESIS; DOWN REGULATION; DRUG EFFECTS; DRUG RESISTANCE; ESOPHAGEAL NEOPLASMS; FEMALE; HUMAN; MALE; METABOLISM; MIDDLE AGED; MOUSE; NUDE MOUSE; PHYSIOLOGY; TUMOR CELL LINE;

AGED; ANIMALS; ANTINEOPLASTIC AGENTS; CELL LINE, TUMOR; DOWN-REGULATION; DRUG RESISTANCE, NEOPLASM; ESOPHAGEAL NEOPLASMS; FEMALE; GPI-LINKED PROTEINS; HUMANS; MALE; MICE; MICE, INBRED BALB C; MICE, NUDE; MICRORNAS; MIDDLE AGED;

EID: 84916598338     PISSN: 07533322     EISSN: 19506007     Source Type: Journal    
DOI: 10.1016/j.biopha.2014.10.023     Document Type: Article

References (31)

1. Yarhusseini A., Sharifzadeh L., Delpisheh A., et al. Survival rate of esophageal carcinoma in Iran-A systematic review and meta-analysis. Iran J Cancer Prev 2014, 7(2):61.
2. Han B., Li W., Sun Y., et al. A prolyl-hydroxylase inhibitor, ethyl-3, 4-dihydroxybenzoate, induces cell autophagy and apoptosis in esophageal squamous cell carcinoma cells via up-regulation of BNIP3 and N-myc downstream-regulated gene-1. PLoS ONE 2014, 9(9):e107204.
3. Wang Z., Qiao Q., Chen M., et al. miR-625 down-regulation promotes proliferation and invasion in esophageal cancer by targeting Sox2. FEBS Lett 2014, 588(6):915-921.
4. Saadatian Z., Masotti A., Fam Z.N.S., et al. Single-nucleotide polymorphisms within MicroRNAs sequences and their 3'UTR target sites may regulate gene expression in gastrointestinal tract cancers. Iran Red Crescent Med J 2014, 16(7):e16659.
5. Fu C., Dong W., Wang Z., et al. The expression of miR-21 and miR-375 predict prognosis of esophageal cancer. Biochem Biophys Res Commun 2014, 446(4):1197-1203.
6. Cui X., Zhao Z., Liu D., et al. Inactivation of miR-34a by aberrant CpG methylation in Kazakh patients with esophageal carcinoma. J Exp Clin Cancer Res 2014, 33(1):20.
7. Zhou K., Yan Y., Zhao S. Esophageal cancer-selective expression of TRAIL mediated by MREs of miR-143 and miR-122. Tumor Biol 2014, 1-9.
8. Wang F., Xia J., Wang X., et al. miR-145 inhibits proliferation and invasion of esophageal squamous cell carcinoma in part by targeting c-Myc. Onkologie 2013, 36(12):8.
9. Zhang M., Yang Q., Zhang L., et al. miR-302b is a potential molecular marker of esophageal squamous cell carcinoma and functions as a tumor suppressor by targeting ErbB4. J Exp Clin Cancer Res 2014, 33(1):10.
10. Zhang N., Fu H., Song L., et al. MicroRNA-100 promotes migration and invasion through mammalian target of rapamycin in esophageal squamous cell carcinoma. Oncol Rep 2014, 32(4):1409-1418.
11. Feng X., Wang Y., Ma Z., et al. MicroRNA-645, up-regulated in human adencarcinoma of gastric esophageal junction, inhibits apoptosis by targeting tumor suppressor IFIT2. BMC Cancer 2014, 14(1):633.
12. Zhang Y., Pan T., Zhong X., et al. Nicotine upregulates microRNA-21 and promotes TGF-β-dependentepithelial- mesenchymal transition of esophageal cancer cells. Tumor Biol 2014, 1-10.
13. Li H., Zheng D., Zhang B., et al. Mir-208 promotes cell proliferation by repressing SOX6 expression in human esophageal squamous cell carcinoma. J Transl Med 2014, 12(1):196.
14. Guo H., Li Q., Li W., et al. miR-96 downregulates RECK to promote growth and motility of non-small cell lung cancer cells. Mol Cell Biochem 2014, 390(1-2):155-160.
15. Lin H., Dai T., Xiong H., et al. Unregulated miR-96 induces cell proliferation in human breast cancer by downregulating transcriptional factor FOXO3a. PLoS ONE 2010, 5(12):e15797.
16. Fendler A., Jung M., Stephan C., et al. The antiapoptotic function of miR-96 in prostate cancer by Inhibition of FOXO1. PLoS ONE 2013, 8(11):e80807.
17. Guo Y., Liu H., Zhang H., et al. miR-96 regulates FOXO1-mediated cell apoptosis in bladder cancer. Oncol Lett 2012, 4(3):561-565.
18. Zhang J., Kong X., Li J., et al. miR-96 promotes tumor proliferation and invasion by targeting RECK in breast cancer. Oncol Rep 2014, 31(3):1357-1363.
19. Liao J., Liu R., Yin L., et al. Expression profiling of exosomal miRNAs derived from human esophageal cancer cells by solexa high-throughput sequencing. Int J Mol Sci 2014, 15(9):15530-15551.
20. Komatsu S., Ichikawa D., Takeshita H., et al. Circulating miR-18a: a sensitive cancer screening biomarker in human cancer. In Vivo 2014, 28(3):293-297.
21. Akanuma N., Hoshino I., Akutsu Y., et al. MicroRNA-133a regulates the mRNAs of two invadopodia-related proteins, FSCN1 and MMP14, in esophageal cancer. Br J Cancer 2014, 110(1):189-198.
22. Shi L., Zhang S., Wu H., et al. MiR-200c increases the radiosensitivity of non-small-cell lung cancer cell line A549 by targeting VEGF-VEGFR2 pathway. PLoS ONE 2013, 8(10):e78344.
23. Lindner K., Borchardt C., Schöpp M., et al. Proton pump inhibitors (PPIs) impact on tumour cell survival, metastatic potential and chemotherapy resistance, and affect expression of resistance-relevant miRNAs in esophageal cancer. J Exp Clin Cancer Res 2014, 33(1):73.
24. Su H., Jin X., Zhang X., et al. Identification of microRNAs involved in the radioresistance of esophageal cancer cells. Cell Biol Int 2014, 38(3):318-325.
25. Shah N.R., Chen H. MicroRNAs in pathogenesis of breast cancer: implications in diagnosis and treatment. World J Clin Oncol 2014, 5(2):48.
26. Zhao H., Wang Y., Yang L., et al. miR-25 promotes gastric cancer cells growth and motility by targeting RECK. Mol Cell Biochem 2014, 385(1-2):207-213.
27. Lei L., Huang Y., Gong W. Inhibition of miR-92b suppresses non-small cell lung cancer cells growth and motility by targeting RECK. Mol Cell Biochem 2014, 387(1-2):171-176.
28. Wang N., Zhang C., He J., et al. MiR-21 down-regulation suppresses cell growth, invasion and induces cell apoptosis by targeting FASL, TIMP3, and RECK genes in esophageal carcinoma. Dig Dis Sci 2013, 58(7):1863-1870.
29. Wang L., Wang Q., Li H.L., et al. Expression of MiR-200a, miR-93, metastasis-related gene RECK and MMP2/MMP9 in human cervical carcinoma-Relationship with prognosis. Asian Pac J Cancer Prev 2013, 14(3):2113-2118.
30. Hirata H., Ueno K., Shahryari V., et al. OncogenicmiRNA-182-5p targets Smad4 and RECK in human bladder cancer. PLoS ONE 2012, 7(11):e51056.
31. Chandana E.P.S., Maeda Y., Ueda A., et al. Involvement of the Reck tumor suppressor protein in maternal and embryonic vascular remodeling in mice. BMC Dev Biol 2010, 10(1):84.